Does KETOCONAZOLE Cause Malignant neoplasm progression? 14 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Malignant neoplasm progression have been filed in association with KETOCONAZOLE (Ketoconazole). This represents 0.3% of all adverse event reports for KETOCONAZOLE.
14
Reports of Malignant neoplasm progression with KETOCONAZOLE
0.3%
of all KETOCONAZOLE reports
6
Deaths
7
Hospitalizations
How Dangerous Is Malignant neoplasm progression From KETOCONAZOLE?
Of the 14 reports, 6 (42.9%) resulted in death, 7 (50.0%) required hospitalization, and 1 (7.1%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for KETOCONAZOLE. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does KETOCONAZOLE Cause?
Drug ineffective (1,326)
Off label use (657)
Pruritus (559)
Product use issue (428)
Product use in unapproved indication (421)
Alopecia (375)
Therapeutic response unexpected (317)
Psoriasis (312)
Rash (267)
Hair texture abnormal (255)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which KETOCONAZOLE Alternatives Have Lower Malignant neoplasm progression Risk?
KETOCONAZOLE vs KETOPROFEN
KETOCONAZOLE vs KETOPROFEN LYSINE
KETOCONAZOLE vs KETOROLAC TROMETHAMINE
KETOCONAZOLE vs KETOROLAC\KETOROLAC TROMETHAMINE
KETOCONAZOLE vs KETOTIFEN